申请人:Bayer Aktiengesellschaft
公开号:US05221681A1
公开(公告)日:1993-06-22
The present invention relates to new substituted benzoxazepines and benzothiazepines of the general formula I ##STR1## in which X, R.sup.1, R.sup.2 and R.sup.3 have the meaning given in the description, processes for their preparation and their use in medicaments having vaso- and muscle-relaxing properties, in particular as circulatory agents.
本发明涉及一种新的取代苯并噁唑啉和苯并噻唑啉,其通式为I ##STR1## 在其中X,R.sup.1,R.sup.2和R.sup.3的含义如描述中所述,以及它们的制备方法和它们在具有血管和肌肉松弛作用的药物中的应用,特别是作为循环药剂。